PHARMA-BIO SERV, INC. Foreign Currency Transaction Gain (Loss), Unrealized
PHARMA-BIO SERV, INC. (PBSV) reported Foreign Currency Transaction Gain (Loss), Unrealized of $36.24 thousand for the 3-month period ending 2026-01-31, per its 10-Q filed 2026-03-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-03-17
- PHARMA-BIO SERV, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2026-01-31 was $36.24K.
- PHARMA-BIO SERV, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-01-31 was -$47.36K.
- PHARMA-BIO SERV, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2024-07-31 was -$12.84K.
- PHARMA-BIO SERV, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2023-07-31 was -$42.47K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month |
|---|---|---|---|
| 2026-01-31 | $36.24K 10-Q · filed 2026-03-17 | ||
| 2025-01-31 | -$47.36K 10-Q · filed 2026-03-17 | ||
| 2024-07-31 | -$12.84K 10-Q · filed 2024-09-16 | -$16.49K 10-Q · filed 2024-09-16 | |
| 2023-07-31 | -$42.47K 10-Q · filed 2024-09-16 | $25.63K derived: sum of 2 quarters · filed 2024-09-16 | $151.78K 10-Q · filed 2024-09-16 |
| 2023-04-30 | $68.10K 10-Q · filed 2023-06-14 | $194.25K 10-Q · filed 2023-06-14 | |
| 2022-07-31 | -$103.36K 10-Q · filed 2023-09-14 | -$154.50K derived: sum of 2 quarters · filed 2023-09-14 | -$179.99K 10-Q · filed 2023-09-14 |
| 2022-04-30 | -$51.14K 10-Q · filed 2023-06-14 | -$76.63K 10-Q · filed 2023-06-14 |